Weiwei Zhang

Weiwei Zhang

Auto-generated profile, based on publicly available information

Weiwei Zhang

School of Business, Central South University, Changsha, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2022 in Group Decision and Negotiation
Verified
Journal Article
Closed access
PDF file
XCXiaohong Chen
Xiaohong Chen
WZWeiwei Zhang
Weiwei Zhang
XXXuanhua Xu
Xuanhua Xu
WCWenzhi Cao
Wenzhi Cao

19 February 2025 in Expert Systems with Applications
Verified
Journal Article
Closed access
JWJinpeng Wei
Jinpeng Wei
XXXuanhua Xu
Xuanhua Xu
WZWeiwei Zhang
Weiwei Zhang
QWQiuhan Wang
Qiuhan Wang

18 August 2025 in Information Fusion
Verified
Journal Article
Closed access
JWJinpeng Wei
Jinpeng Wei
XXXuanhua Xu
Xuanhua Xu
YJYing Ji
Ying Ji
SQShaojian Qu
Shaojian Qu
QWQiuhan Wang
Qiuhan Wang
Francisco Javier CabrerizoFrancisco Javier Cabrerizo
Francisco Javier Cabrerizo

1 August 2020 in Translational Cancer Research
Verified
Journal Article
Open access
PDF file
WWWenzhi Wu
Wenzhi Wu
SXShengnan Xu
Shengnan Xu
KGKaiyu Guan
Kaiyu Guan
WZWeiwei Zhang
Weiwei Zhang
CCCongde Chen
Congde Chen
HDHua Dong
Hua Dong
Background: 5-fluorouracil (5-FU) is a common chemotherapy drug for gastric cancer. Human antigen R (HuR) is an RNA-binding protein that is also known as ELAV like RNA binding protein 1 (ELAVL1) regulates gene expression by binding to target genes 3' UTR region and is highly expressed in tumor tissues. However, the regulatory mechanisms of HuR in 5-FU mediated chemotherapy in stomach cancer are not well understood. In this study, we aimed to investigate 5-FU regulated PKCδ expression and translocation of HuR in SGC cell lines. Methods: Using Cell viability assay to obtained IC50 doses when SGC cells were treated with 5-FU for 2 and 3 days. Western blot was used to detect the total protein content of HuR and PKCδ after treating with 20 mM 5-FU. Furthermore, after adding 20 mM 5-FU, knocking down PKCδ, HuR and using inhibitor Staurosporine respectively, the protein content of HuR in the cytoplasm were detected by Western blot and Immunofluorescence. MTT assay was used to verify the changes in cell proliferation after knockdown of HuR. Results: Using Cell viability assay, we obtained IC50 doses of 77 and 20 mM, respectively, when SGC cells were treated with 5-FU for 2 and 3 days. The total protein content of HuR and PKCδ in SGC cells treated with 20 mM 5-FU did not change. However, Western blot and Immunofluorescence detected that the protein content of HuR in the cytoplasm decreased with 20 mM 5-FU treatment. Staurosporine inhibits the nucleation of HuR and is an inhibitor of PKC. Consistently, the expression of HuR in cytoplasm declined while knockdown of PKCδ. And the proliferation of SGC cells decreased after knocking down the HuR. Conclusions: Our results showed that 5-FU blocked shuttling of HuR from the nucleus to the cytoplasm in SGC cells through PKCδ phosphorylation.